1st Global Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$783K Sell
14,821
-1,172
-7% -$62.8K 0.09% 178
2017
Q1
$889K Buy
15,993
+2,810
+21% +$155K 0.1% 146
2016
Q4
$687K Sell
13,183
-2,184
-14% -$105K 0.09% 193
2016
Q3
$742K Buy
+15,367
New +$777K 0.1% 184
2015
Q1
Sell
-18,219
Closed -$633K 489
2014
Q4
$633K Sell
18,219
-917
-5% -$30.4K 0.09% 173
2014
Q3
$619K Buy
19,136
+348
+2% +$11.6K 0.1% 164
2014
Q2
$637K Sell
18,788
-809
-4% -$25.9K 0.1% 162
2014
Q1
$534K Buy
19,597
+2,227
+13% +$66.2K 0.1% 167
2013
Q4
$622K Sell
17,370
-939
-5% -$31.2K 0.12% 125
2013
Q3
$551K Sell
18,309
-4,710
-20% -$154K 0.11% 133
2013
Q2
$671K Buy
+23,019
New +$649K 0.15% 91

Other funds holding PBH

1st Global Advisors's PBH Position: Q2 2017 in Review

1st Global Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 7.3% in Q2 2017, selling an estimated $62.8K and leaving 14,821 shares worth $783K. The position accounts for 0.09% of the portfolio, ranked #178.

1st Global Advisors first reported a position in PBH in Q2 2013 and has held it in 11 quarters since. The position peaked at $889K in Q1 2017. 232 funds tracked by Wall St. Rank hold PBH as of Q2 2017.

  • 1st Global Advisors held 14,821 shares of Prestige Consumer Healthcare worth $783K as of Q2 2017.
  • 1st Global Advisors sold 1,172 Prestige Consumer Healthcare shares in Q2 2017, an estimated $62.8K.
  • Prestige Consumer Healthcare made up 0.09% of 1st Global Advisors's portfolio in Q2 2017, its #178 holding.
  • 1st Global Advisors first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 11 quarters since.
  • 1st Global Advisors's Prestige Consumer Healthcare position peaked at $889K in Q1 2017.
  • 232 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.